Generic drugs not gain­ing ground

Kathimerini English - - Front Page -

Greeks are re­sist­ing ef­forts to pro­mote the use of generic medicines over more costly brand-name drugs, with genomes ac­count­ing for just 25 per­cent of to­tal sales today com­pared to 18.5 per­cent be­fore the start of the crisis.

Given that cred­i­tors had set a tar­get of 60 per­cent in or­der to curb state ex­pen­di­tures on medicine, Brus­sels is frus­trated with Greece’s lack of progress.

Mea­sures so far in­clude leg­is­la­tion forc­ing pa­tients to pay a larger per­cent­age when pur­chas­ing brand-name drugs in­stead of their generic equiv­a­lents and drug com­pa­nies grant­ing phar­ma­cists a dis­count when they ex­ceed a 25-per­cent tar­get in genome sales.

Ac­cord­ing to phar­ma­cists, the main rea­son why generic drugs have failed to take off is that Greeks dis­trust drugs they do not know and that pa­tients with chronic con­di­tions on ex­pen­sive med­i­ca­tions are afraid of switch­ing to a dif­fer­ent drug.

Newspapers in English

Newspapers from Greece

© PressReader. All rights reserved.